23
04 '19
One of many positive features of our new Online Longitudinal Assessment (OLA) is its ability to immediately tell a diplomate whether he or she answered a question correctly.
While the majority of diagnostic radiology diplomates and subspecialties are faring well on OLA, there naturally have been incorrect responses submitted to the more than 380,000 questions issued since the system started this past January. So what happens then?
Anyone who submits a wrong answer will receive a similar question several weeks later. Our analytics show that most diplomates correctly answer the second question. This suggests that participants are noting the rationale feedback and possibly seeking out OLA references to learn more before receiving the next question in that topic area.
As is the case with all our exams, OLA questions are written by professionals from the field. We work with more than 1,000 volunteers each year to ensure our content is relevant to the many disciplines it covers.
Interventional radiology, medical physics, and radiation oncology diplomates will start OLA in January. They will have an opportunity to try the system later this year before it goes live. We will schedule interactive webinars before and after OLA rolls out for those fields.
17
04 '19
Lisa Kachnic, MD, a former American Board of Radiology president, one of the nation’s leading radiation oncologists and a pioneer of new approaches to optimize the effectiveness of radiation therapy, has been named chair of the Department of Radiation Oncology at the Columbia University Vagelos College of Physicians and Surgeons and chief of the radiation oncology service at NewYork-Presbyterian/Columbia University Irving Medical Center, effective September 1. She will also serve as associate director for cancer network strategy in the Herbert Irving Comprehensive Cancer Center.
Dr. Kachnic is professor and chair of the department of radiation oncology at the Vanderbilt University School of Medicine. She previously served on the radiation oncology faculty at Massachusetts General Hospital and Boston University School of Medicine. She is a fellow of the American Society for Radiation Oncology (ASTRO).
A member of the ABR Board of Governors, Dr. Kachnic is internationally known for her clinical trial leadership positions in the National Cancer Institute (NCI) and its cooperative group research bases. She is widely recognized for gastrointestinal research that has transformed the standard of care for several cancers by integrating novel radiation delivery techniques. She is vice chair of the radiation oncology committee and co-chair of the ano-rectal subcommittee for the SWOG Cancer Research Network research base, where she serves as the multi-modality executive officer. Dr. Kachnic is also the chair of the NRG Oncology (National Surgical Adjuvant Breast & Bowel Project, Radiation Therapy Oncology Group and the Gynecological Oncology Group) NCI Community Oncology Research Program’s Cancer Control and Prevention Division, and is actively involved in NRG Oncology’s GI strategic committee.
In addition to her strong research portfolio and national leadership profile, Dr. Kachnic is also recognized by her peers for her history of mentoring colleagues and junior faculty. She is a member of several professional organizations, including the American Society of Clinical Oncology, and chairs the scientific committee for ASTRO’s annual meeting.
Dr. Kachnic earned an undergraduate degree from Boston College and a medical degree from Tufts University School of Medicine. She completed a residency in radiation oncology at Harvard University, her last year as chief resident.
16
04 '19
